AI can effectively exclude pathology in chest X-rays

A commercial artificial intelligence (AI) tool used off-label was effective at excluding pathology and had equal or lower rates of critical misses on chest X-ray than radiologists, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).

Novartis pays $1B upfront for PTC’s Phase 2 Huntington’s drug

Novartis is returning to Huntington’s disease with a $1 billion upfront bet, plus another $1.9 billion in biobucks, for access to a Phase 2 oral

December 3, 2024

Wild and feral cats living in places with higher human population density shed more toxoplasmosis parasites

A new analysis suggests that wild, stray, and feral cats living in areas with higher human population density tend to release-;or “shed”-;a greater amount of

June 22, 2023

Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024 – Biotech Investments

Medacta Group SA / Key word(s): Sales Result 04-Feb-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

February 5, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.